Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edivoxetine Adjunctive to SSRI in MDD Partial Responders
NCT01187407Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of edivoxetine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started Mar 2011; status: completed.
02
Drugs
edivoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01187407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187407.